Publications by authors named "Diederik van Bodegom"

Claim this Profile
H
HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma.
Caron Jacobson, Nadja Kopp, Jacob V Layer, Robert A Redd, Sebastian Tschuri, Diederik van Bodegom

Blood· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia.
Shuo-Chieh Wu, Loretta S Li, Nadja Kopp, Joan Montero, Bjoern Chapuy, Diederik van Bodegom

Cancer Cell· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling.
Jun Zhong, Jyoti Sharma, Rajesh Raju, Shyam Mohan Palapetta, T S Keshava Prasad, Diederik van Bodegom

Database (Oxford)· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation.
Andrew A Lane, Bjoern Chapuy, Charles Y Lin, Trevor Tivey, Hubo Li, Diederik van Bodegom

Nat Genet· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
Oreofe Odejide, Oliver Weigert, Andrew A Lane, Dan Toscano, Matthew A Lunning, Diederik van Bodegom

Blood· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2.
Diederik van Bodegom, Jun Zhong, Nadja Kopp, Chaitali Dutta, Min-Sik Kim

Blood· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCL2 suppresses PARP1 function and nonapoptotic cell death.
Chaitali Dutta, Tovah Day, Nadja Kopp, Diederik van Bodegom, Matthew S Davids

Cancer Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition.
Oliver Weigert, Andrew A Lane, Liat Bird, Nadja Kopp, Bjoern Chapuy, Diederik van Bodegom

J Exp Med· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of p53-mediated repression of the human polycystic kidney disease-1 promoter.
Diederik van Bodegom, Wijnand Roessingh, Andrew Pridjian, Samir S El Dahr

Biochim Biophys Acta· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The polycystic kidney disease-1 gene is a target for p53-mediated transcriptional repression.
Diederik Van Bodegom, Zubaida Saifudeen, Susana Dipp, Sanjeev Puri, Brenda S Magenheimer

J Biol Chem· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis